Work

Can overall survival (OS) benefit be predicted from improvements in progression-free survival (PFS) for previously untreated metastatic colorectal cancer (mCRC)?

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.4_suppl.222

Authors: Jeanine Roodhart, Kiran Dave, Matthew Dixon, Murat Kurt, Divya Pushkarna, Mir-Masoud Pourrahmat, Mir Sohail Fazeli

Institutions: University Medical Center Utrecht, Bristol-Myers Squibb (United Kingdom), Bristol-Myers Squibb (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406869753

Cites:

Cited by: 1

Related to: 10